✦ LIBER ✦

Discovery of Novel 1,2,4-Triazol-5-Ones as Tumor Necrosis Factor-Alpha Inhibitors for the Treatment of Neuropathic Pain

✍ Scribed by Sharma, Monika; Garigipati, Sowmya; Kundu, Binita; Vanamala, Deekshith; Semwal, Arvind; Sriram, Dharmarajan; Yogeeswari, Perumal

Book ID: 119827212
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 233 KB
Volume: 80
Category: Article
ISSN: 1747-0277
DOI: 10.1111/cbdd.12049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of 3-(4-bromophenyl)-6-nitrobe

Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-α production

✍ Chien-Shu Chen; Chen-Ming Tan; Chiung-Hua Huang; Ling-Chu Chang; Jih-Pyang Wang; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 658 KB

ChemInform Abstract: Discovery of 3-(3-C

ChemInform Abstract: Discovery of 3-(3-Cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 — A Xanthine Oxidoreductase Inhibitor for the Treatment of Hyperuricemia.

✍ Takahiro Sato; Naoki Ashizawa; Koji Matsumoto; Takashi Iwanaga; Hiroshi Nakamura 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 17 KB 👁 1 views

Discovery of Novel 2-Anilinopyrazolo[1,5

Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke.

✍ Harunobu Mukaiyama; Toshihiro Nishimura; Hiroaki Shiohara; Satoko Kobayashi; Yos 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 39 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Discovery of 4-Heteroarylbicyclo[2.2.2]o

Discovery of 4-Heteroarylbicyclo[2.2.2]octyltriazoles as Potent and Selective Inhibitors of 11β-HSD1: Novel Therapeutic Agents for the Treatment of Metabolic Syndrome.

✍ Xin Gu; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 15 KB

Novel Imidazol-1-ylmethyl Substituted 1,

Novel Imidazol-1-ylmethyl Substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1- ij ]quinolin-4-ones as Potent and Selective CYP11B1 Inhibitors for the Treatment of Cushing’s Syndrome

✍ Yin, Lina; Lucas, Simon; Maurer, Frauke; Kazmaier, Uli; Hu, Qingzhong; Hartmann, 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 288 KB

Identification and Characterization of 4

Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis

✍ Zhang, Y. 📂 Article 📅 2004 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 387 KB